You are here » Home » Companies » Company Overview » Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Ltd.

BSE: 532296 Sector: Health care
NSE: GLENMARK ISIN Code: INE935A01035
BSE 00:00 | 31 Mar 206.05 10.45
(5.34%)
OPEN

201.60

HIGH

207.40

LOW

197.00

NSE 00:00 | 31 Mar 205.85 10.10
(5.16%)
OPEN

199.00

HIGH

208.00

LOW

197.00

OPEN 201.60
PREVIOUS CLOSE 195.60
VOLUME 54575
52-Week high 667.00
52-Week low 168.00
P/E 4.52
Mkt Cap.(Rs cr) 5,815
Buy Price 205.50
Buy Qty 238.00
Sell Price 206.00
Sell Qty 10.00
OPEN 201.60
CLOSE 195.60
VOLUME 54575
52-Week high 667.00
52-Week low 168.00
P/E 4.52
Mkt Cap.(Rs cr) 5,815
Buy Price 205.50
Buy Qty 238.00
Sell Price 206.00
Sell Qty 10.00
Filter:

Glenmark Pharmaceuticals Ltd. (GLENMARK) - Financial Overview

Particulars ( cr) 2019 2018 2017
Net Sales 6304.87 5520.44 7989.23
Operating Profit 2282.08 1429.49 2810.43
Other Income 954.61 328.48 148.24
Interest 223.81 190.90 152.60
Depreciation 106.28 95.93 104.93
Profit Before Tax 1951.99 1142.66 2552.90
Tax 329.88 128.31 412.29
Profit After Tax 1622.11 1014.35 2140.61
 
Share Capital 28.22 28.22 28.22
Reserves 11913.87 10363.22 9408.40
Net Worth 11942.09 10391.44 9436.62
Loans 3222.99 2983.67 2778.94
Gross Block 2260.10 2581.75 2368.53
Investments 3268.75 3212.68 1866.70
Cash 256.48 177.38 252.18
Debtors 2087.13 3828.91 3879.40
Net Working Capital 10196.65 8043.63 8481.83
 
Operating Profit Margin (%) 36.20 25.89 35.18
Net Profit Margin (%) 25.73 18.37 26.79
Earning Per Share (Rs) 57.49 35.95 75.86
Dividend (%) 200.00 200.00 200.00
Dividend Payout 56.43 56.43 56.43